Pyelonephritis Treatment Guidelines

First-Line Agents for Mild-to-Moderate Pyelonephritis

The Infectious Diseases Society of America recommends fluoroquinolones as the preferred oral agents for mild-to-moderate pyelonephritis when local resistance is <10% 1, 2, 3
Ciprofloxacin 500mg twice daily for 7 days or 1000mg extended-release daily for 7 days is a recommended treatment regimen 1
Levofloxacin 750mg once daily for 5 days is an alternative treatment option 1

The IDSA/ESMID guidelines state that oral beta-lactam agents like Augmentin are less effective than other available agents for pyelonephritis, with lower microbiological cure rates and requiring longer treatment durations 1, 4
Augmentin may be considered for pyelonephritis treatment if the causative organism is proven susceptible on culture, but it should be used for 10-14 days and only after an initial IV dose of ceftriaxone or aminoglycoside 1, 4, 5
The WHO 2024 AWaRe guidelines do not recommend amoxicillin-clavulanic acid for pyelonephritis, reserving it for lower urinary tract infections 2, 3, 6

For hospitalized patients, IV fluoroquinolone (ciprofloxacin 400mg every 8-12 hours) or extended-spectrum cephalosporin (ceftriaxone or cefotaxime) are recommended treatment options 5, 2, 3
Aminoglycoside with or without ampicillin, or carbapenem for resistant organisms, may also be considered 5, 4

Delaying appropriate antibiotic therapy can worsen outcomes, and treatment should be initiated promptly, even before urine culture results are available 7
Urinary obstruction should always be assessed, and urgent decompression via percutaneous nephrostomy may be necessary in cases of pyonephrosis 7
Nephrotoxic medications like NSAIDs should be discontinued to prevent worsening AKI in pyelonephritis 7

The Infectious Diseases Society of America recommends fluoroquinolones as the preferred oral agents for mild-to-moderate pyelonephritis when local resistance is <10%, with cefuroxime axetil considered only as a second-line option after initial parenteral therapy 8

Always give an initial parenteral dose of ceftriaxone 1g IM/IV or aminoglycoside (gentamicin 5-7 mg/kg) before starting oral therapy with cefuroxime axetil for pyelonephritis 8
Consider local resistance patterns, and in areas with fluoroquinolone resistance >10%, initial parenteral therapy becomes mandatory 8